Evidence map›Paper›PMID 38371482›Full record

ArticleJournal of pain research2024

Exacerbation of Pre-Existing Chronic Pain in Older Adults After SARS-CoV-2 Infection: A Single-Center, Cross-Sectional, Observational Study.

Chenhui Wang, Lei Han, Yuru Li, Xibin Mi, Mengwei Yan, Xinxiu Yu, Yu Lu, Meihong Shi, Pengfei Liu, Liang Han and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of pain research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Chenhui WangDepartment of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, People's Republic of China.ORCID 0000-0001-5978-3175
Lei HanInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Yuru LiInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Xibin MiDepartment of Pain Management, Yanyuan Rehabilitation Hospital, Beijing, People's Republic of China.
Mengwei YanDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.ORCID 0000-0002-2259-7755
Xinxiu YuInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Yu LuInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Meihong ShiInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Pengfei LiuInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Liang HanInfirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China.
Baoguo WangDepartment of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, People's Republic of China.
Community Care · USCapital Medical University · CNPain Management Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To identify the prevalence of exacerbation of pre-existing chronic pain after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and investigate the impact of exacerbated previous chronic pain on quality of life, sleep quality, anxiety and depression levels and risk factors associated with exacerbated chronic pain among elderly coronavirus disease of 2019 (COVID-19) survivors. Patients and Methods: In this cross-sectional study, elderly COVID-19 survivors with chronic pain residing in Continuing Care Retirement Community (CCRC) were recruited from April 2023 to June 2023. Eligible individuals were divided into exacerbation and non-exacerbation groups based on the patient-reported worsening symptoms of previous chronic pain after SARS-CoV-2 infection. Baseline information, COVID-19 symptoms, laboratory parameters, characteristics of exacerbated chronic pain, quality of life, anxiety and depression levels were systematically collected. Results: Ninety-five (95/441, 21.5%) older adults suffered from exacerbated chronic pain with a median numerical rating scale (NRS) score of 6 (4-7) on a median duration of 4.9 (4.3-5.6) months after SARS-CoV-2 infection. More participants were not vaccinated against COVID-19 (46.5%, 40/86 vs 26.1%, 86/330, P < 0.001) in exacerbation group. Exacerbation group exhibited poor quality of life (EQ5D index: 0.734 [0.536-0.862] vs 0.837 [0.716-0.942], P < 0.001), more severe anxiety (GAD-7: 2 [0-5] vs 0 [0-3], P < 0.001) and depression (PHQ-9: 4 [2-7] vs 2.5 [0-5], P < 0.001) than non-exacerbation group. Risk factors significantly associated with exacerbation of pre-existing chronic pain were neuropathic pain (aOR 4.81, 95% CI 1.73-13.32, P = 0.003), lymphocyte count (aOR 0.31, 95% CI 0.12-0.78, P = 0.013) and D-dimer levels (aOR 6.46, 95% CI 1.92-21.74, P = 0.003). Conclusion: Our study observed a prevalence of 21.5% exacerbation of pre-existing chronic pain after SARS-CoV-2 infection, with a consequence of poor quality of life, more severe anxiety and depression. Previous chronic neuropathic pain, lower lymphocyte count and higher D-dimer levels were risk factors associated with the development of exacerbated previous chronic pain.

Indexed as

chronic painexacerbated symptomsolder adultspost-COVID-19

Identifiers

PMID38371482
PMCPMC10871137
OpenAlexW4391752010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.